Recent genomic evidence suggests frequent phosphatidylinositide 3-kinase (PI3K) pathway activation in human papillomavirus (HPV) positive oropharyngeal squamous cell carcinoma. This evidence concerns the gene PIK3CA and oropharynx squamous cell carcinoma.